ERBB2 and prostate cancer: However, the potential role of ERBB2 in the development of metastatic prostate cancer is unclear partly because various attempts to assess frequencies of ERBB2 amplification/overexpression in human prostate cancer samples yielded inconsistent results [16]–[25].